Neogenomics Inc. (NASDAQ:NEO) At $15.30: What To Do?

In last trading session, Neogenomics Inc. (NASDAQ:NEO) saw 0.88 million shares changing hands with its beta currently measuring 1.17. Company’s recent per share price level of $15.30 trading at $0.58 or 3.94% at ring of the bell on the day assigns it a market valuation of $1.95B. That closing price of NEO’s stock is at a discount of -38.69% from its 52-week high price of $21.22 and is indicating a premium of 27.91% from its 52-week low price of $11.03. Taking a look at company’s average trading volume volume of 949.24K if we extend that period to 3-months.

Neogenomics Inc. (NASDAQ:NEO) trade information

Upright in the green during last session for gaining 3.94%, in the last five days NEO remained trading in the green while hitting it’s week-highest on Monday, 04/29/24 when the stock touched $15.30 price level, adding 4.67% to its value on the day. Neogenomics Inc.’s shares saw a change of -5.44% in year-to-date performance and have moved 8.20% in past 5-day. Neogenomics Inc. (NASDAQ:NEO) showed a performance of 3.45% in past 30-days.

Neogenomics Inc. (NEO) estimates and forecasts

Statistics highlight that Neogenomics Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company added 11.11% of value to its shares in past 6 months, showing an annual growth rate of 116.67% while that of industry is 12.80. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 10.80% from the last financial year’s standing.

12 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 162.22M for the same. And 12 analysts are in estimates of company making revenue of 166.04M in the next quarter. Company posted 137.42M and 151.95M of sales in current and next quarters respectively a year earlier.

NEO Dividends

Neogenomics Inc. is more likely to be releasing its next quarterly report in June and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.